Coagulation Factor IX Protein (F9)

Catalog No. ABIN934813

Native Coagulation Factor IX protein expressed in Human.

Quick Overview for Coagulation Factor IX Protein (F9) (ABIN934813)

Target: Coagulation Factor IX (F9)

Protein Type: Native

Biological Activity: Active

Origin: Human

Source: Human

Purity: > 95 % pure

Product Details

Characteristics: Purified native Human Factor IX protein
Bioactivity: 258 units/mg protein - Specific activity is determined by the Factor IX clotting assay. One unit of activity is equivalent to the Factor IX activity in one milliliter of normal human plasma.
Protein Source: Human serum/plasma

Application Details

Application Notes: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Supplied as a liquid with 50 % Glycerol/H2 O (vol/vol).

Precaution of Use: Donor samples were tested and found to be negative for anti-HIV-1/2, HIV-1 antigen(s), HBsAg, STS, anti-HCV, anti-HBcore and anti-HTLV I & II. Nonetheless caution should be used when handling this material as there is a margin of error in all tests.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: -20 °C

Storage Comment: Aliquot and store at -20 °C.

Target Details

Target: Coagulation Factor IX (F9)

Alternative Name: Factor IX

Background: The zymogen factor IX is a single chain vitamin K-dependent glycoprotein which is synthesized in the liver. The domain structure of factor IX is similar to that of the other vitamin K dependent coagulation factors. The NH2-terminal region contains 12 gama-carboxyglutamic acid (gla) residues which facilitate the calcium dependent binding of factor IX to negatively charged phospholipid surfaces.
Description: Human serum/plasma.
Alternative Names: Complement Factor IX

Molecular Weight: 55 kDa